Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Cerecin is a Biotechnology Research brand in Anson House, Singapore. Ownership is privately held; it publishes at cerecin.com. The record carries two addresses across two office countries. The record counts 35 people. Tagged clinical research and biotechnology. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Series B, US$7.2M. It is listed alongside four similar brands, mostly in Wellness and Fitness Services.
UEN201810260R
| CERECIN PTE. LTD. | UEN 201810260R |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Cerecin is a global healthcare company with more than 20 years of innovation and leadership in brain health.
At Cerecin we think differently. We develop novel evidence-based solutions that help people; pharmaceuticals, medical foods, diagnostics, medical devices and e-health products. These solutions target conditions ranging from memory impairment to some of the most devastating neurological diseases.
| Countries | 2 |
|---|---|
| Primary country | SG |
All codes: SG US
| Rounds | 5 |
|---|---|
| Axis | 2023 to 2026 |
| Series B · 28 Oct 2022 | US$ 7.2M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Singapore entity on ACRA. CERECIN PTE. LTD. (UEN 201810260R), high confidence.
The record holds 35 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Two addresses on record across 2 countries. Primary: 72 Anson Road, #06-01, Anson House, Singapore 079911.
Five rounds. Latest 28 October 2022: Series B, US$7,200,000, investors SK Securities and K&T partners.
Six tags on the brand's own list, among them clinical research and biotechnology.
4 profiles list Cerecin as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. Remesleep and Juvoxa list it back.